LISINOPRIL
NDC 70518-1790, Lisinopril, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-1790
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076180
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL2.5 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-1790-2 | 70518179002 | 100 TABLET in 1 BOTTLE, PLASTIC (70518-1790-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/42f49299-7ae5-4d30-86eb-66b739c0e95d
Use it
Look up 70518-1790 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-1790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.